98-5673. Manufacturer of Controlled Substances; Notice of Application
[Federal Register Volume 63, Number 43 (Thursday, March 5, 1998)]
[Notices]
[Page 10945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-5673]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on December 30, 1997,
Mallinckrodt Chemical, Inc., Mallinckrodt & Second Streets, St. Louis,
Missouri 63147, made application by renewal to the Drug Enforcement
Administration (DEA) for registration as a bulk manufacturer of the
basic classes of controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Methylphenidate (1724)..................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Diprenorphine (9058)....................... II
Etorphine Hydrochloride (9059)............. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Diphenoxylate (9170)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Methadone-intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Opium extracts (9610)...................... II
Opium fluid extract (9620)................. II
Opium tincture (9630)...................... II
Opium powdered (9639)...................... II
opium granulated (9640).................... II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Alfentanil (9737).......................... II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The firm plans to manufacture the controlled substances for
distribution bulk products to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than May 4, 1998.
Dated: February 13, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-5673 Filed 3-4-98; 8:45 am]
BILLING CODE 4410-09-M
Document Information
- Published:
- 03/05/1998
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- 98-5673
- Pages:
- 10945-10945 (1 pages)
- PDF File:
-
98-5673.pdf